EcoDrugPlus

Ribosomal Protein L10 Like

Ensembl ID : ENSOKIG00005013056
Gene Symbol: RPL10L
1 Cross references
18 Possible Orthologues:

Ribosomal Protein L10a

Ensembl ID : ENSOKIG00005047577
Gene Symbol: RPL10A
1 Cross references
363 Possible Orthologues:

Ribosomal Protein L11

Ensembl ID : ENSOKIG00005016939
Gene Symbol: RPL11
1 Cross references
282 Possible Orthologues:

Ribosomal Protein L12

Ensembl ID : ENSOKIG00005036665
Gene Symbol: RPL12
3 Cross references
478 Possible Orthologues:

Ribosomal Protein L13a

Ensembl ID : ENSOKIG00005009206
Gene Symbol: RPL13A
1 Cross references
362 Possible Orthologues:

Ribosomal Protein L17

Ensembl ID : ENSOKIG00005018873
Gene Symbol: RPL17
1 Cross references
705 Possible Orthologues:

Ribosomal Protein L17

Ensembl ID : ENSOKIG00005019091
Gene Symbol: RPL17
1 Cross references
705 Possible Orthologues:

Ribosomal Protein L18a

Ensembl ID : ENSOKIG00005044239
Gene Symbol: RPL18A
3 Cross references
363 Possible Orthologues:

Ribosomal Protein L19

Ensembl ID : ENSOKIG00005014021
Gene Symbol: RPL19
3 Cross references
344 Possible Orthologues:

Ribosomal Protein L21

Ensembl ID : ENSOKIG00005021604
Gene Symbol: LOC109899252
3 Cross references
778 Possible Orthologues:

Ribosomal Protein L22

Ensembl ID : ENSOKIG00005046576
Gene Symbol: RPL22
1 Cross references
160 Possible Orthologues:

Ribosomal Protein L23

Ensembl ID : ENSOKIG00005005351
Gene Symbol: RPL23
3 Cross references
226 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).